Table 2. Cox multiple factors regression analyses for independent risk factors of the primary and secondary endpoints.
Variables | Primary endpoint |
Secondary endpoint |
||||
P | HR | 95% CI | P | HR | 95% CI | |
Age | 0.034 | 1.040 | 1.003–1.078 | 0.031 | 1.028 | 1.003–1.054 |
Body mass index | 0.506 | 0.981 | 0.926–1.039 | 1 | 1 | 0.970–1.030 |
Smoking | 0.265 | 1.472 | 0.746–2.906 | 0.648 | 1.138 | 0.653–1.984 |
Drug type (ARB or ACEI) | 0.037 | 2.124 | 1.048–4.306 | 0.137 | 1.454 | 0.888–2.380 |
Coronary heart disease | 0.660 | 1.127 | 0.661–1.923 | 0.001 | 1.913 | 1.320–2.772 |
Diabetes mellitus | 0.582 | 1.174 | 0.663–2.080 | 0.258 | 1.29 | 0.830–2.005 |
Cerebral infarction | 0.006 | 2.239 | 1.257–3.988 | 0.778 | 0.928 | 0.552–1.560 |
Hyperlipidemia | 0.233 | 0.560 | 0.216–1.453 | 0.156 | 0.599 | 0.295–1.215 |
Cardiac dysfunction | 0.859 | 1.089 | 0.425–2.793 | 0.274 | 0.621 | 0.265–1.457 |
Renal dysfunction | 0.035 | 1.423 | 1.025-1.976 | 0.416 | 0.837 | 0.545–1.286 |
ACEI: angiotensin II converting enzyme inhibitor; ARB: angiotensin receptor blocker.